MedPath

Evaluation of perioperative landiolol administration for preventing atrial fibrillation during esophagectomy.

Not Applicable
Conditions
Esophageal cancer(Esophagectomy)
Registration Number
JPRN-UMIN000024040
Lead Sponsor
Shizuoka General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
188
Inclusion Criteria

Not provided

Exclusion Criteria

(1) history of arrhythmias (atrial fibrillation, atrioventricular block, etc.) (2) bradycardia from the preoperative period (heart rate 50 / min or less) (3) thyroid dysfunction (hyperthyroidism, hypothyroidism) (4) B blocker use from the preoperative period (5) history of asthma (6) heart failure hospitalizations, low cardiac function in the preoperative echocardiography (left ventricular ejection fraction less than 30%) (7) untreated pheochromocytoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Perioperative atrial fibrillation incidence (within 96 hours)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath